Joinn Laboratories (6127.HK) - Concerns Begin to Arise when the Monkeys Become More Expensive

543 Views01 Dec 2021 01:06
The article mainly analyzed Joinn about the concerns on its accounting treatment of biological assets, future fair value changes,current business layout, strategy,CXO industry trend and policy impact.
Boomeranged on Mon, 17 Jul 2023 09:17
Joinn is the company with the strongest cyclical attribute in CXO sector, mainly because its performance growth is closely related with changes in fair value of monkeys. So, its poor results in 23H1 is in line with our analysis (stock price down 77%). Looking forward, expectation of other CXO would also go down. After hitting the industry bottom, we need to wait for the macro shift of the industry
SUMMARY
(Sign Up to Access)
Full Insight
(Paid Plans Only, 5-minute read)
Discussions
(Paid Plans Only)
chart-bar
x